HomeNewsIndiaCoronavirus pandemic | Parle to donate 3 cr Parle G biscuit packs through government agencies

Coronavirus pandemic | Parle to donate 3 cr Parle G biscuit packs through government agencies

The company said its manufacturing units are functioning with 50 percent of workforce keeping with government advisories to curb escalation of the coronavirus outbreak, but it is working to ensure that sufficient quantity of its products are available in the market.

March 25, 2020 / 19:56 IST
Story continues below Advertisement


Biscuits major Parle Products on March 25 said it will donate three crore packs of biscuits in the next three weeks, especially to the needy people through government agencies with the country going for a 21-day lockdown due to coronavirus pandemic.

The company said its manufacturing units are functioning with 50 per cent of workforce keeping with government advisories to curb the escalation of the coronavirus outbreak, but it is working to ensure that sufficient quantity of its products is available in the market.

Story continues below Advertisement

"We have decided to work with the government, donate through government agency three crore packs of biscuits - one crore each in the next three weeks - especially for people in need...We will be donating one crore packs of Parle G biscuits every week for the next three weeks, effectively about three crore packs of biscuits," Parle Products Senior Senior Category Head Mayank Shah said.

He further said, "We are also looking at ensuring those who need food right now -- there will be many people whose livelihood will be hampered, we will work very closely with the government to ensure that they don't go hungry."

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show